No definition available.
Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)
C3_SMALL_INTESTINE_ADENO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma of small intestine
- Malignant neoplasm of small intestine
- Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 37 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 68.91 | 65.83 | 71.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 83
- Matched controls
- 830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
65.5
54
*
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
42.4
37
*
L01BC06
ATC
capecitabine; oral
+∞
42.4
37
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
34.9
31
*
H02AB02
ATC
dexamethasone; systemic
188.0
34.8
34
*
A03FA01
ATC
metoclopramide; systemic, rectal
22.1
29.5
47
46
JFB00
NOMESCO Finland
Partial resection of small intestine
115.1
29.1
30
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
98.2
25.6
27
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
+∞
25.3
23
*
A04AA02
ATC
granisetron; systemic, transdermal
331.9
25.1
24
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
24.1
22
*
8140/3-C17.9
ICD-O-3
Adenocarcinoma, NOS, of small intestine, NOS
+∞
23.0
21
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
23.0
21
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
21.8
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.8
20
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
80.8
17.6
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
17.3
16
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
17.3
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
23.5
16.9
24
14
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
45.2
15.2
18
5
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
180.5
15.0
15
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
22.9
14.8
21
12
A04AA01
ATC
ondansetron; systemic, rectal
52.5
14.8
17
*
JN4AD
NOMESCO Finland
Body CT examination
25.8
14.6
20
10
Z51.5
ICD-10 Finland
Palliative care
32.2
14.1
18
7
8140/3-C17.2
ICD-O-3
Adenocarcinoma, NOS, of ileum
+∞
13.9
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.1
13.4
50
165
JN4BD
NOMESCO Finland
Extensive body CT
14.0
13.3
23
22
JAH00
NOMESCO Finland
Laparotomy
36.0
12.1
15
5
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.7
11
*
8140/3-C17.1
ICD-O-3
Adenocarcinoma, NOS, of jejunum
+∞
11.7
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
11.7
11
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.3
11.1
21
24
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.6
10
*
JN3AD
NOMESCO Finland
Abdominal CT examination
10.0
10.4
21
27
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
20.0
10.3
15
9
N02AA05
ATC
oxycodone; systemic
6.2
10.2
30
69
TPX10
NOMESCO Finland
Implantation of vascular injection port
30.4
10.2
13
5
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
10.2
10.1
20
25
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.6
9.9
24
42
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
41.7
9.3
11
*
B01AB10
ATC
tinzaparin; parenteral
12.1
9.0
16
16
UJF92
NOMESCO Finland
Capsular endoscopy
56.1
8.9
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.7
8.9
36
117
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
8.5
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.4
8.0
33
107
WX402
NOMESCO Finland
General anaesthesia
5.9
7.6
22
48
UJF32
NOMESCO Finland
Coloscopy
4.1
7.6
37
137
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
87.6
7.5
8
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
+∞
7.4
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.4
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.4
7
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
7.4
7
*
WW500
NOMESCO Finland
Blood transfusion
22.4
7.3
10
5
R4190
NOMESCO Finland
Nutritional therapy
33.2
7.3
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.8
7.3
21
46
JAH01
NOMESCO Finland
Laparoscopy
15.6
7.1
11
8
A02BC02
ATC
pantoprazole; systemic
3.8
6.9
65
402
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.5
6.7
40
174
R11
ICD-10 Finland
Nausea and vomiting
6.8
6.6
16
28
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
K83.1
ICD-10 Finland
Obstruction of bile duct
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.5
6.1
22
61
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
6.0
27
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
19
15
15.93
20.10
1.6
1.3
126.4
315.0
ug/g
—
14
8
64
258
6.60
15.42
8.0
3.5
—
—
—
0
0
62
272
5.45
12.69
14.4
3.4
32.1
35.5
g/l
4.40
62
255
34
96
5.17
11.95
7.3
2.0
0.8
0.8
mmol/l
0.99
34
84
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
17
9.62
10.93
2.1
1.8
0.3
0.3
u/ml
—
9
8
39
133
4.50
10.67
4.5
2.0
—
—
—
0
0
10
12
9.29
7.74
1.8
3.3
3.0
3.5
g/l
—
10
12
16
39
4.80
6.41
1.5
1.2
—
—
—
0
0
58
334
3.21
6.24
10.0
4.5
1.2
1.2
mmol/l
1.78
52
284
27
103
3.35
5.84
1.7
1.7
—
—
—
0
0
21
72
3.53
5.32
5.9
2.0
24.4
34.1
u/l
1.51
21
58
19
72
3.10
4.05
1.6
1.6
—
—
—
0
0
31
156
2.53
3.89
1.9
1.9
1457.0
1158.8
nmol/l
0.62
25
117
43
252
2.40
3.87
3.7
2.9
—
—
—
0
0
6
5
12.74
3.82
1.5
1.2
26.3
29.8
umol/l
—
6
5
13
40
3.65
3.80
1.8
1.3
—
—
—
0
0
18
70
2.98
3.66
5.2
3.0
—
—
—
0
0
18
73
2.85
3.39
1.7
1.7
—
—
—
0
0
6
7
9.09
3.31
1.2
4.0
234.2
202.9
%
—
6
7
13
44
3.30
3.29
1.6
1.8
—
—
—
0
0
8
15
5.75
3.27
7.4
1.7
46.3
76.4
u/ml
—
8
15
6
8
7.95
3.10
1.0
1.0
—
—
—
0
0
6
9
7.06
2.91
1.0
1.0
—
—
—
0
0
8
18
4.78
2.87
1.3
1.1
—
—
—
0
0
34
200
2.15
2.86
3.9
3.0
0.4
0.4
e6/l
0.06
28
146
6
11
5.77
2.59
1.0
1.1
—
—
—
0
0
5
7
7.49
2.58
1.0
1.6
69.4
76.5
pmol/l
—
5
7
23
120
2.25
2.56
3.0
2.7
3.9
0.7
e6/l
1.08
12
61
20
104
2.20
2.23
2.1
1.7
29.6
29.8
s
0.09
20
97
8
25
3.42
2.15
1.8
1.7
—
—
—
0
0
43
310
1.77
1.82
2.8
2.0
89.2
93.9
pmol/l
0.26
26
153
59
686
0.57
1.59
4.0
5.7
2.5
2.6
mmol/l
0.31
51
631
24
151
1.81
1.56
4.6
3.4
140.6
112.4
ng/l
0.09
19
122
55
650
0.58
1.55
3.6
4.5
1.1
1.3
mmol/l
1.69
47
589
20
119
1.88
1.55
3.1
2.9
3.0
2.4
e6/l
—
9
62
58
676
0.57
1.54
3.8
5.1
4.2
4.5
mmol/l
0.99
51
625
6
21
2.99
1.53
1.8
1.7
—
—
—
0
0
58
670
0.60
1.37
3.7
5.0
1.3
1.5
mmol/l
2.48
51
614
8
39
2.16
1.19
5.0
2.2
0.9
1.2
%
—
8
39
42
331
1.52
1.10
9.2
5.1
0.0
0.0
estimate
—
10
59
54
623
0.65
1.09
5.1
4.7
2.0
1.9
mu/l
0.02
49
562
0
30
0.00
0.99
0.0
1.6
—
—
—
0
0
42
339
1.46
0.94
6.4
3.7
0.0
0.1
estimate
—
9
54
41
332
1.44
0.89
6.6
3.6
0.0
0.0
estimate
—
10
57
22
160
1.50
0.81
2.2
1.9
378.3
435.5
pmol/l
0.62
16
125
23
173
1.45
0.72
6.0
3.9
0.0
0.0
estimate
—
10
57
12
78
1.62
0.70
15.7
7.9
—
—
—
0
0
5
27
1.90
0.69
1.0
1.3
—
—
—
0
0
5
27
1.90
0.69
1.0
1.3
—
—
—
0
0
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
6
35
1.77
0.59
1.0
1.4
—
—
—
0
0
39
332
1.32
0.57
2.6
2.4
—
—
—
0
0
9
64
1.45
0.53
1.3
1.3
—
—
—
0
0
30
253
1.28
0.45
7.9
3.8
—
—
—
0
0
25
298
0.77
0.45
4.6
4.0
1.8
1.9
ug/l
0.05
18
270
0
17
0.00
0.41
0.0
1.3
—
45.0
—
0
17
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
35
308
1.23
0.36
4.9
3.8
21.9
57.1
ng/l
1.97
26
229
10
74
1.40
0.34
1.8
2.6
5.8
5.6
ug/l
—
10
64
19
224
0.81
0.30
3.9
3.8
24.2
24.7
%
—
8
102
64
673
0.81
0.30
4.4
5.0
6.1
6.1
mmol/l
0.06
59
610
68
706
0.83
0.23
57.4
15.6
79.2
82.4
umol/l
0.24
68
706
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
55
523
1.14
0.18
4.5
4.3
22.3
12.9
mm/h
2.08
49
478
18
158
1.18
0.18
2.3
2.8
0.9
0.8
ug/l
—
9
112
62
640
0.89
0.13
46.0
12.5
78.5
74.0
ml/min/173m2
0.84
57
523
5
45
1.12
0.10
4.6
3.4
5.2
5.0
kpa
—
5
36
51
506
1.02
0.00
4.2
3.8
14.9
14.9
pmol/l
0.10
45
448
0
5
0.00
0.00
0.0
1.4
—
114.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
15.4
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_SMALL_INTESTINE_ADENO_EXALLC – Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).